Pluristem (PSTI) Says PLX-R18 Improves Hematopoietic Transplantation as Reported in Scientific Journal Frontiers in Medicine
Tweet Send to a Friend
Pluristem Therapeutics Inc. (Nasdaq: PSTI) announced today that Frontiers in Medicine has published key findings from a study of PLX-R18 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
